Neurogene Inc (NAS:NGNE)
$ 25.43 -0.37 (-1.43%) Market Cap: 377.76 Mil Enterprise Value: 253.30 Mil PE Ratio: 0 PB Ratio: 2.41 GF Score: 20/100

Neoleukin Therapeutics Inc Annual Shareholders Meeting Transcript

May 05, 2020 / 08:30PM GMT
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the 2020 Stockholders' Annual Meeting of Neoleukin Therapeutics. (Operator Instructions)

I would now like to hand the conference over to your speaker, Mr. Bob Ho. Please go ahead.

Robert Ho
Neoleukin Therapeutics, Inc. - CFO & Secretary

Thanks, Amanda. Good afternoon. I am Bob Ho, Secretary and Chief Financial Officer of Neoleukin Therapeutics, Inc., which we will refer to as Neoleukin and what follows. Welcome to our 2020 annual meeting. I would like to introduce Dr. Jonathan Drachman, our Chief Executive Officer, President and Member of the Board of Directors, who will call the meeting to order. Jonathan?

Jonathan G. Drachman
Neoleukin Therapeutics, Inc. - CEO, President & Director

Thanks, Bob. Good afternoon. My name is Jonathan Drachman. I am the Chief Executive Officer, President and the Director of Neoleukin. I now call the meeting to order.

With us here today are the following members of our Board of Directors: Dr.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot